The Effect of Organic Lithium Salts on Plasma 8-Hydroxy-2' Deoxyguanosine in Bipolar Patients In Vitro; Psychopharmacology Bulletin; Vol. 50, iss. 1

Detalles Bibliográficos
Parent link:Psychopharmacology Bulletin
Vol. 50, iss. 1.— 2020.— [P. 19-27]
Autor Corporativo: Национальный исследовательский Томский политехнический университет Исследовательская школа химических и биомедицинских технологий
Outros autores: Prokopjeva V. D. Valentina Danilovna, Yarygina E. G., Bokhan N. A. Nikolay Aleksandrovich, Plotnikov E. V. Evgeny Vladimirovich
Summary:Title screen
Objective: An important step in the development of new drugs for the treatment of bipolar disorder (BD) is the study of the extent to which novel lithium salts whose anionic component has an antioxidant effect can reduce oxidative DNA damage in human blood plasma in vitro. We investigated the effects of lithium salts containing different organic anionic components (lithium carbonate (Li-CAR), pyruvate (Li-PYR), succinate (Li-SUC), fumarate (Li-FUM) and ascorbate (Li-ASC)) on levels of the oxidative damage product of DNA-8-hydroxy-2'-deoxyguanosine (8-OH-dG) in blood plasma after incubation of blood samples from healthy individuals (healthy group) and patients with bipolar disorder (BD-group) with these chemical compounds. Methods: Blood incubation was carried out in the presence of lithium salts (1.2 mM) for 1 hour at 37°C. Measurement of 8-OH-dG concentrations in blood plasma was carried out by enzyme immunoassay using a DNA Damage Competitive Elisa Kit (Thermo Fisher Scientific, USA). Results: In samples without compounds (control), concentrations of 8-OH-dG in the BD-group did not differ from the group of healthy individuals. None of the tested compounds had a significant effect on 8-OH-dG in healthy individuals. In BD patients, Li-PYR significantly reduced levels of plasma 8-OH-dG, while other compounds did not have a noticeable effect. Conclusion: Lithium pyruvate reduces oxidative DNA damage in the blood of BD patients in vitro, demonstrating the potential of this compound to function not only as a mood stabilizer, but also as an antioxidant and cytoprotector.
Idioma:inglés
Publicado: 2020
Subjects:
Acceso en liña:https://www.ncbi.nlm.nih.gov/pubmed/32214518
Formato: Electrónico Capítulo de libro
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=666368

MARC

LEADER 00000naa0a2200000 4500
001 666368
005 20250214171044.0
035 |a (RuTPU)RU\TPU\network\37572 
035 |a RU\TPU\network\37571 
090 |a 666368 
100 |a 20211220d2020 k||y0rusy50 ba 
101 0 |a eng 
135 |a drgn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a The Effect of Organic Lithium Salts on Plasma 8-Hydroxy-2' Deoxyguanosine in Bipolar Patients In Vitro  |f V. D. Prokopjeva, E. G. Yarygina, N. A. Bokhan, E. V. Plotnikov 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 30 tit.] 
330 |a Objective: An important step in the development of new drugs for the treatment of bipolar disorder (BD) is the study of the extent to which novel lithium salts whose anionic component has an antioxidant effect can reduce oxidative DNA damage in human blood plasma in vitro. We investigated the effects of lithium salts containing different organic anionic components (lithium carbonate (Li-CAR), pyruvate (Li-PYR), succinate (Li-SUC), fumarate (Li-FUM) and ascorbate (Li-ASC)) on levels of the oxidative damage product of DNA-8-hydroxy-2'-deoxyguanosine (8-OH-dG) in blood plasma after incubation of blood samples from healthy individuals (healthy group) and patients with bipolar disorder (BD-group) with these chemical compounds. Methods: Blood incubation was carried out in the presence of lithium salts (1.2 mM) for 1 hour at 37°C. Measurement of 8-OH-dG concentrations in blood plasma was carried out by enzyme immunoassay using a DNA Damage Competitive Elisa Kit (Thermo Fisher Scientific, USA). Results: In samples without compounds (control), concentrations of 8-OH-dG in the BD-group did not differ from the group of healthy individuals. None of the tested compounds had a significant effect on 8-OH-dG in healthy individuals. In BD patients, Li-PYR significantly reduced levels of plasma 8-OH-dG, while other compounds did not have a noticeable effect. Conclusion: Lithium pyruvate reduces oxidative DNA damage in the blood of BD patients in vitro, demonstrating the potential of this compound to function not only as a mood stabilizer, but also as an antioxidant and cytoprotector. 
461 |t Psychopharmacology Bulletin 
463 |t Vol. 50, iss. 1  |v [P. 19-27]  |d 2020 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a 8-hydroxy-2’-deoxyguanosine (8-OH-dG) 
610 1 |a bipolar disorder 
610 1 |a blood plasma 
610 1 |a lithium 
610 1 |a pyruvate. 
610 1 |a биполярное расстройство 
610 1 |a плазма крови 
610 1 |a литий 
610 1 |a пируват 
610 1 |a органические соли 
701 1 |a Prokopjeva  |b V. D.  |g Valentina Danilovna 
701 1 |a Yarygina  |b E. G. 
701 1 |a Bokhan  |b N. A.  |g Nikolay Aleksandrovich 
701 1 |a Plotnikov  |b E. V.  |c chemist  |c Associate Professor of Tomsk Polytechnic University, Candidate of Chemical Sciences  |f 1983-  |g Evgeny Vladimirovich  |3 (RuTPU)RU\TPU\pers\32469  |9 16417 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Исследовательская школа химических и биомедицинских технологий  |c (2017- )  |3 (RuTPU)RU\TPU\col\23537 
801 2 |a RU  |b 63413507  |c 20211220  |g RCR 
856 4 |u https://www.ncbi.nlm.nih.gov/pubmed/32214518 
942 |c CF